Molecular and neurological features of MELAS syndrome in paediatric patients: A case series and review of the literature.
Publication Date
2022-07Journal Title
Mol Genet Genomic Med
ISSN
2324-9269
Publisher
Wiley
Language
en
Type
Article
This Version
AO
VoR
Metadata
Show full item recordCitation
Seed, L. M., Dean, A., Krishnakumar, D., Phyu, P., Horvath, R., & Harijan, P. D. (2022). Molecular and neurological features of MELAS syndrome in paediatric patients: A case series and review of the literature.. Mol Genet Genomic Med https://doi.org/10.1002/mgg3.1955
Description
Funder: Addenbrooke’s Charitable Trust, Cambridge University Hospitals; Id: http://dx.doi.org/10.13039/501100002927
Funder: European Research Council; Id: http://dx.doi.org/10.13039/100010663
Funder: Evelyn Trust; Id: http://dx.doi.org/10.13039/501100004282
Funder: Medical Research Council; Id: http://dx.doi.org/10.13039/501100007155
Funder: Newton Fund; Id: http://dx.doi.org/10.13039/100010897
Funder: the Lily Foundation
Funder: The Stoneygate Trust
Funder: Wellcome Trust; Id: http://dx.doi.org/10.13039/100010269
Abstract
BACKGROUND: Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome is one of the most well-known mitochondrial diseases, with most cases attributed to m.3243A>G. MELAS syndrome patients typically present in the first two decades of life with a broad, multi-systemic phenotype that predominantly features neurological manifestations--stroke-like episodes. However, marked phenotypic variability has been observed among paediatric patients, creating a clinical challenge and delaying diagnoses. METHODS: A literature review of paediatric MELAS syndrome patients and a retrospective analysis in a UK tertiary paediatric neurology centre were performed. RESULTS: Three children were included in this case series. All patients presented with seizures and had MRI changes not confined to a single vascular territory. Blood heteroplasmy varied considerably, and one patient required a muscle biopsy. Based on a literature review of 114 patients, the mean age of presentation is 8.1 years and seizures are the most prevalent manifestation of stroke-like episodes. Heteroplasmy is higher in a tissue other than blood in most cases. CONCLUSION: The threshold for investigating MELAS syndrome in children with suspicious neurological symptoms should be low. If blood m.3243A>G analysis is negative, yet clinical suspicion remains high, invasive testing or further interrogation of the mitochondrial genome should be considered.
Keywords
ORIGINAL ARTICLE, ORIGINAL ARTICLES, encephalopathy, genetics, lactic acidosis, m.3243A>G, MELAS syndrome, mitochondrial disease, paediatric neurology, stroke‐like episodes
Sponsorship
MRC (MR/V009346/1)
Wellcome Trust (109915_A_15_Z)
Identifiers
mgg31955, mgg3-2021-12-1888.r1
External DOI: https://doi.org/10.1002/mgg3.1955
This record's URL: https://www.repository.cam.ac.uk/handle/1810/336500
Rights
Licence:
http://creativecommons.org/licenses/by/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk